Stephen Michael Kelsey - 20 Jun 2023 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President, Research and Development
Signature
/s/ Jack Anders, as Attorney-in-fact for Stephen Michael Kelsey
Issuer symbol
RVMD
Transactions as of
20 Jun 2023
Net transactions value
-$52,321
Form type
4
Filing time
22 Jun 2023, 16:26:53 UTC
Previous filing
21 Mar 2023
Next filing
03 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Sale $52,321 -2,102 -0.64% $24.89 325,780 20 Jun 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units ("RSUs") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
F2 Includes 1,513 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023.
F3 Includes 70,738 RSUs.

Remarks:

President, Research and Development